CRISPR Therapeutics (NASDAQ:CRSP) Earns “Market Outperform” Rating from JMP Securities
JMP Securities restated their market outperform rating on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research note published on Tuesday, Benzinga reports. The brokerage currently has a $74.00 price target on the stock. Other analysts have also recently issued research reports about the company. Royal Bank of Canada dropped their target price […]
More Stories
Greenup Street Wealth Management LLC Sells 4,626 Shares of Tesla, Inc. (NASDAQ:TSLA)
Greenup Street Wealth Management LLC trimmed its position in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 19.5% in...
Compass Wealth Management LLC Sells 68 Shares of Costco Wholesale Co. (NASDAQ:COST)
Compass Wealth Management LLC cut its holdings in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 2.4% during the 3rd...
BCS Wealth Management Increases Holdings in AT&T Inc. (NYSE:T)
BCS Wealth Management lifted its stake in AT&T Inc. (NYSE:T – Free Report) by 1.7% in the 3rd quarter, according...
iShares MSCI EAFE ETF (NYSEARCA:EFA) Stock Position Lifted by Sax Wealth Advisors LLC
Sax Wealth Advisors LLC boosted its position in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA – Free Report) by 22.9%...
Trifecta Capital Advisors LLC Raises Stock Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Trifecta Capital Advisors LLC lifted its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by...
Marshall Financial Group LLC Takes $1.01 Million Position in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Marshall Financial Group LLC acquired a new stake in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) in the...